ESI National Preferred Formulary Exclusion Changes

What is the value of managing drug trend across both the pharmacy and medical benefit?

Opportunity Offered by a Good Crisis: COVID-19 IMPACT ON INNOVATIVE PRICING MODELS

Drug Coverage in the Pandemic: US Payers Shift Focus From Costs To Access, For Now